We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

161 hedge funds and large institutions have $713M invested in PharMerica Corporation in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

1% less funds holding

Funds holding: 162161 (-1)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

15% less capital invested

Capital invested by funds: $839M → $713M (-$126M)

78% less call options, than puts

Call options by funds: $51K | Put options by funds: $230K

Holders
161
Holders Change
-1
Holders Change %
-0.62%
% of All Funds
4.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
59
Reduced
59
Closed
20
Calls
$51K
Puts
$230K
Net Calls
-$179K
Net Calls Change
+$490K
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$55.6M +$2.38M +89,690 +4%
BFA
2
BlackRock Fund Advisors
California
$41.1M -$735K -27,709 -2%
Ameriprise
3
Ameriprise
Minnesota
$40.5M +$20.8M +785,483 +90%
Vanguard Group
4
Vanguard Group
Pennsylvania
$33.1M +$2.92M +110,279 +9%
Invesco
5
Invesco
Georgia
$30.6M +$4.73M +178,257 +17%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$28.2M +$7.18M +270,671 +31%
MCM
7
Munder Capital Management
Michigan
$24.8M +$7.63M +287,800 +40%
LSV Asset Management
8
LSV Asset Management
Illinois
$23.5M -$3.68M -138,898 -13%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$23M -$6.88M -259,289 -22%
BIT
10
BlackRock Institutional Trust
California
$20.3M -$305K -11,517 -1%
Bank of America
11
Bank of America
North Carolina
$16.9M -$118K -4,461 -0.6%
State Street
12
State Street
Massachusetts
$14.6M -$186K -7,028 -1%
KCM
13
Kennedy Capital Management
Missouri
$14.6M +$2.64M +99,482 +20%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$14.6M -$1.83M -68,855 -10%
CCM
15
Century Capital Management
Massachusetts
$14.5M
SFM
16
Systematic Financial Management
New Jersey
$12.6M +$1.19M +44,949 +10%
JP Morgan Chase
17
JP Morgan Chase
New York
$12.4M -$4.99M -188,048 -27%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$12.2M +$2.65M +100,000 +25%
SGCIA
19
Smith Graham & Co Investment Advisors
Texas
$12M -$368K -13,880 -3%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$11.1M +$890K +33,558 +8%
AQR Capital Management
21
AQR Capital Management
Connecticut
$10.1M -$1.11M -41,800 -9%
TSW
22
Thompson Siegel & Walmsley
Virginia
$9.27M +$3.35M +126,290 +50%
Northern Trust
23
Northern Trust
Illinois
$8.88M -$322K -12,154 -3%
TA
24
Teachers Advisors
New York
$8.14M +$3.25M +122,633 +58%
Norges Bank
25
Norges Bank
Norway
$7.61M -$6.4M -241,425 -44%

PMC Hedge Fund Activity: Q3 2014 in Review

161 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q3 2014, worth a combined $713M — down 15% from $839M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PMC and 19 opened new positions — a net loss of 1 holder — while 59 trimmed existing stakes and 59 added.

The largest buyer was Ameriprise, adding an estimated $20.8M. The largest seller was Kestrel Investment Management, cutting an estimated $10.3M.

  • 161 institutional investors held PharMerica Corporation (PMC) as of Q3 2014, down from 162 in Q2 2014.
  • Funds reported $713M of PharMerica Corporation stock for Q3 2014, down 15% quarter-over-quarter.
  • 19 funds opened new PharMerica Corporation positions in Q3 2014 and 20 closed out, a net change of -1 holder.
  • The largest PharMerica Corporation buyer in Q3 2014 was Ameriprise, an estimated $20.8M added.
  • The largest PharMerica Corporation seller in Q3 2014 was Kestrel Investment Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q3 2014.